Sandbox:DAMI: Difference between revisions

Jump to navigation Jump to search
Line 6: Line 6:
*  
*  
====Common Risk Factors====
====Common Risk Factors====
* Idiopathic
* Drugs (12765)
* Drugs (12765)
** Spironolactone
** Spironolactone
Line 19: Line 21:
** INH
** INH
** [[Digoxin]]<ref name="pmid8421478">{{cite journal| author=Braunstein GD| title=Gynecomastia. | journal=N Engl J Med | year= 1993 | volume= 328 | issue= 7 | pages= 490-5 | pmid=8421478 | doi=10.1056/NEJM199302183280708 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8421478  }} </ref>
** [[Digoxin]]<ref name="pmid8421478">{{cite journal| author=Braunstein GD| title=Gynecomastia. | journal=N Engl J Med | year= 1993 | volume= 328 | issue= 7 | pages= 490-5 | pmid=8421478 | doi=10.1056/NEJM199302183280708 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8421478  }} </ref>
* Idiopathic
* Cirrhosis
* Cirrhosis
* Starvation and Refeeding
* Starvation and Refeeding

Revision as of 15:03, 18 May 2017


Gynecomastia

Risk factors

Common Risk Factors

  • Idiopathic
  • Drugs (12765)
    • Spironolactone
    • Cimetidine
    • Recombinant Human Growth Hormone
    • Estrogens
    • Human Chorionic gonadotropin
    • Anti-androgens
    • Gonadotropin Releasing hormone (GNRH) agonists
    • 5-alpha reductase inhibitors
    • Ketoconazole
    • steroids
    • INH
    • Digoxin[1]
  • Cirrhosis
  • Starvation and Refeeding
  • Male hypogonadism
  • Testicular neoplasms
  • Hyperthyroidism
  • Chronic Kidney disease
  • Tumors

Less Common Risk Factors

  • Feminizing adrenal tumors
  • Ectopic hCG
  • Disorders of sex development
  • Familial prepubertal gynecomastia

Causes

History and Symptoms

Physical Examination

References

  1. Braunstein GD (1993). "Gynecomastia". N Engl J Med. 328 (7): 490–5. doi:10.1056/NEJM199302183280708. PMID 8421478.